The podcast episode covers a range of topics, starting with a discussion on Elon Musk's TerraFab presentation and the feasibility of projects like space data centers and lunar mass drivers. The hosts then transition to a debate on peptides, featuring Martin Shkreli and Max from Superpower, discussing the safety, regulation, and potential benefits of both FDA-approved and non-approved peptides like BPC-157. Later segments include an interview with Mitchell Green from Lead Edge Capital on software investment strategies and a conversation with Robin Vince from BNY Mellon on AI's impact on financial institutions and the future of digital assets. The episode also touches on the role of AI in creative work with Shane from AIR and explores AI-driven healthcare solutions with Adam from Doctronic.
Sign in to continue reading, translating and more.
Continue